CN111019884A - 一种抑制人羊膜上皮细胞上皮间质转化的方法 - Google Patents
一种抑制人羊膜上皮细胞上皮间质转化的方法 Download PDFInfo
- Publication number
- CN111019884A CN111019884A CN201911412105.7A CN201911412105A CN111019884A CN 111019884 A CN111019884 A CN 111019884A CN 201911412105 A CN201911412105 A CN 201911412105A CN 111019884 A CN111019884 A CN 111019884A
- Authority
- CN
- China
- Prior art keywords
- epithelial cells
- human amniotic
- cells
- amniotic epithelial
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003425 amniotic epithelial cell Anatomy 0.000 title claims abstract description 119
- 230000007705 epithelial mesenchymal transition Effects 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 27
- 210000004027 cell Anatomy 0.000 claims abstract description 74
- 230000014509 gene expression Effects 0.000 claims abstract description 67
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 238000000338 in vitro Methods 0.000 claims abstract description 9
- 239000003550 marker Substances 0.000 claims description 46
- 238000012544 monitoring process Methods 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 5
- 239000012930 cell culture fluid Substances 0.000 claims description 3
- 239000006143 cell culture medium Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 210000000130 stem cell Anatomy 0.000 abstract description 25
- 230000035755 proliferation Effects 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 description 39
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 33
- 101000975496 Homo sapiens Keratin, type II cytoskeletal 8 Proteins 0.000 description 30
- 229940079593 drug Drugs 0.000 description 26
- 239000003814 drug Substances 0.000 description 26
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 20
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 20
- 102100036732 Actin, aortic smooth muscle Human genes 0.000 description 19
- 101000929319 Homo sapiens Actin, aortic smooth muscle Proteins 0.000 description 19
- 239000002771 cell marker Substances 0.000 description 19
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 18
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 18
- 239000000186 progesterone Substances 0.000 description 16
- 229960003387 progesterone Drugs 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 210000002919 epithelial cell Anatomy 0.000 description 14
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 11
- 238000003753 real-time PCR Methods 0.000 description 11
- 102000013127 Vimentin Human genes 0.000 description 10
- 108010065472 Vimentin Proteins 0.000 description 10
- 239000000090 biomarker Substances 0.000 description 10
- 210000005048 vimentin Anatomy 0.000 description 10
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 9
- 108010070511 Keratin-8 Proteins 0.000 description 9
- 210000001691 amnion Anatomy 0.000 description 9
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 8
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000004663 cell proliferation Effects 0.000 description 7
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 6
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 5
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000001671 embryonic stem cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 102100025805 Cadherin-1 Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 3
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 210000001654 germ layer Anatomy 0.000 description 3
- 230000004957 immunoregulator effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 2
- 101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108010066302 Keratin-19 Proteins 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 2
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 2
- 101100257363 Mus musculus Sox2 gene Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 230000001772 anti-angiogenic effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 239000002458 cell surface marker Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000003633 gene expression assay Methods 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010052946 Activin Receptors Proteins 0.000 description 1
- 102000018918 Activin Receptors Human genes 0.000 description 1
- 102100034134 Activin receptor type-1B Human genes 0.000 description 1
- 102100034135 Activin receptor type-1C Human genes 0.000 description 1
- 208000031873 Animal Disease Models Diseases 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 1
- 101000764817 Chromohalobacter salexigens (strain ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11) Oxygen-dependent choline dehydrogenase 1 Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 102000012804 EPCAM Human genes 0.000 description 1
- 101150084967 EPCAM gene Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000011786 HLA-A Antigens Human genes 0.000 description 1
- 108010075704 HLA-A Antigens Proteins 0.000 description 1
- 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 1
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000799189 Homo sapiens Activin receptor type-1B Proteins 0.000 description 1
- 101000799193 Homo sapiens Activin receptor type-1C Proteins 0.000 description 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100037596 Platelet-derived growth factor subunit A Human genes 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 102100028656 Sigma non-opioid intracellular receptor 1 Human genes 0.000 description 1
- 101150057140 TACSTD1 gene Proteins 0.000 description 1
- 102100033456 TGF-beta receptor type-1 Human genes 0.000 description 1
- 108010011702 Transforming Growth Factor-beta Type I Receptor Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000011558 animal model by disease Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000008556 epithelial cell proliferation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 108010080097 sigma-1 receptor Proteins 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000012879 subculture medium Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
基因 | 产品货号 | 来源 | Dye |
CDH 1 | Hs01023895_m1 | Human | FAM-MGB |
CK8 | Hs01595539_g1 | Human | FAM-MGB |
CK19 | Hs00761767_s1 | Human | FAM-MGB |
OCT4 | Hs04260367_gH | Human | FAM-MGB |
KLF4 | Hs00358836_m1 | Human | FAM-MGB |
ACTA2 | Hs00426835_g1 | Human | FAM-MGB |
Vimentin | Hs00958111_m1 | Human | FAM-MGB |
GAPDH | Hs02786624_g1 | Human | VIC-MGB |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911412105.7A CN111019884B (zh) | 2019-12-31 | 2019-12-31 | 一种抑制人羊膜上皮细胞上皮间质转化的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911412105.7A CN111019884B (zh) | 2019-12-31 | 2019-12-31 | 一种抑制人羊膜上皮细胞上皮间质转化的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111019884A true CN111019884A (zh) | 2020-04-17 |
CN111019884B CN111019884B (zh) | 2022-01-07 |
Family
ID=70197601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911412105.7A Active CN111019884B (zh) | 2019-12-31 | 2019-12-31 | 一种抑制人羊膜上皮细胞上皮间质转化的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111019884B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112716979A (zh) * | 2021-01-26 | 2021-04-30 | 上海优祺生物医药科技有限公司 | 羊膜上皮细胞条件培养基的制药用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026279A1 (en) * | 2003-04-28 | 2005-02-03 | Tseng Scheffer C.G. | Surgical grafts and methods of preparation |
US20160339061A1 (en) * | 2015-05-20 | 2016-11-24 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
US20180051258A1 (en) * | 2015-04-03 | 2018-02-22 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
CN109504650A (zh) * | 2017-09-15 | 2019-03-22 | 海门雨霖细胞科技有限责任公司 | 小分子诱导人成纤维细胞直接重编程为肝细胞的方法 |
-
2019
- 2019-12-31 CN CN201911412105.7A patent/CN111019884B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026279A1 (en) * | 2003-04-28 | 2005-02-03 | Tseng Scheffer C.G. | Surgical grafts and methods of preparation |
US20180051258A1 (en) * | 2015-04-03 | 2018-02-22 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
US20160339061A1 (en) * | 2015-05-20 | 2016-11-24 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
CN109504650A (zh) * | 2017-09-15 | 2019-03-22 | 海门雨霖细胞科技有限责任公司 | 小分子诱导人成纤维细胞直接重编程为肝细胞的方法 |
Non-Patent Citations (1)
Title |
---|
ANTONIA ALCARAZ: "Autocrine TGF-β Induces Epithelial to Mesenchymal Transition in Human Amniotic Epithelial Cells", 《CELL TRANSPLANTATION》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112716979A (zh) * | 2021-01-26 | 2021-04-30 | 上海优祺生物医药科技有限公司 | 羊膜上皮细胞条件培养基的制药用途 |
CN112716979B (zh) * | 2021-01-26 | 2022-11-04 | 上海优祺生物医药科技有限公司 | 羊膜上皮细胞条件培养基的制药用途 |
Also Published As
Publication number | Publication date |
---|---|
CN111019884B (zh) | 2022-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chan et al. | Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis | |
Nekanti et al. | Long-term expansion and pluripotent marker array analysis of Wharton’s jelly-derived mesenchymal stem cells | |
KR20080104850A (ko) | 태반 융모막판막-유래 중간엽 줄기 세포의 고순도 분리방법 | |
KR101982801B1 (ko) | 망막색소상피 분화 유도용 조성물 | |
KR20200139799A (ko) | 재프로그래밍 벡터 | |
JP6942363B2 (ja) | 多能性幹細胞の分化制御方法 | |
Breindel et al. | Epigenetic reprogramming of lineage-committed human mammary epithelial cells requires DNMT3A and loss of DOT1L | |
CN105861425B (zh) | 透明质酸促人羊膜干细胞增殖的方法及其应用 | |
US20140162366A1 (en) | Generation of vascular progenitor cells | |
CN104726500A (zh) | MicroRNA26b-3p抑制剂在制备人脐带来源间充质干细胞中的应用 | |
CN111019884B (zh) | 一种抑制人羊膜上皮细胞上皮间质转化的方法 | |
KR20120006386A (ko) | 1기 태반조직 유래 줄기세포 및 이를 함유하는 세포치료제 | |
Abraham et al. | Propagation of human embryonic and induced pluripotent stem cells in an indirect co-culture system | |
Polisetti et al. | Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture | |
Chen et al. | Cryopreservation and recovery of human endometrial epithelial cells with high viability, purity, and functional fidelity | |
US20140106448A1 (en) | Methods of isolating cells | |
WO2007091409A1 (ja) | 組織幹細胞由来フィーダー細胞 | |
JP2022007610A (ja) | 多能性幹細胞由来フィーダー細胞 | |
RU2382077C1 (ru) | Способ выделения и культивирования аутологичных дермальных фибробластов для стимуляции регенеративных процессов и заместительной терапии | |
CN113249328B (zh) | EpCAM在调控人肝前体细胞肝向分化中的应用 | |
KR101984227B1 (ko) | 줄기세포의 층분리 배양 및 증식 방법 | |
CN109852587B (zh) | 一种人科凯恩氏综合征特异性成体干细胞的制备方法 | |
Chen et al. | Establishment of human endometriosis-derived immortalized eutopic endometrium stromal and epithelial cell lines | |
Doberstein et al. | Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis | |
KR20130019459A (ko) | 양수-유래 중간엽 줄기세포의 증식방법 및 이를 포함하는 이식용 구조체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230825 Address after: Building 7, No. 1699 Huishan Avenue, Huishan Economic Development Zone, Wuxi City, Jiangsu Province, 214174, Zone A on the first floor, Zone A on the second floor, and Zone B on the second floor Patentee after: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. Address before: 201210 building 3, Faraday Road, China (Shanghai) free trade pilot area, Pudong New Area, Shanghai, China (3) Patentee before: SHANGHAI CELLULAR BIOPHARMACEUTICAL Group Ltd. Patentee before: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231225 Address after: North Zone, 1st Floor, Building 1, No. 159 Cailun Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, 201210 Patentee after: Shibiman Biotechnology (Shanghai) Co.,Ltd. Address before: Building 7, No. 1699 Huishan Avenue, Huishan Economic Development Zone, Wuxi City, Jiangsu Province, 214174, Zone A on the first floor, Zone A on the second floor, and Zone B on the second floor Patentee before: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. |